ARTICLE | Clinical News
Macugen pegaptanib regulatory update
February 6, 2006 8:00 AM UTC
EC approved an MAA for Macugen pegaptanib sodium injection to treat neovascular wet age-related macular degeneration (AMD). The pegylated oligonucleotide aptamer that binds to vascular endothelial gr...